Marie-Christine Wolf

Title: Marie-Christine Wolf: Innovator in Pharmaceutical Chemistry

Introduction

Marie-Christine Wolf is a prominent inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of MEK inhibitors. With a total of 7 patents to her name, her work has had a substantial impact on drug formulation and preparation.

Latest Patents

Among her latest patents, Marie-Christine Wolf has focused on the preparation of and formulation comprising a MEK inhibitor. This invention relates to processes for preparing 6-(4-bromo-2-fluorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethyoxy)-amide. Additionally, she has developed processes for preparing crystallized versions of this compound and intermediates useful for these processes. Furthermore, her patents include pharmaceutical compositions that comprise this crystallized compound.

Career Highlights

Marie-Christine has worked with notable companies in the pharmaceutical industry, including Array Biopharma Inc. and Novartis AG. Her experience in these organizations has allowed her to refine her expertise in drug development and formulation.

Collaborations

Throughout her career, Marie-Christine has collaborated with esteemed colleagues such as Christoph Max Krell and Marian Misun. These partnerships have contributed to her innovative work in the field.

Conclusion

Marie-Christine Wolf is a distinguished inventor whose contributions to pharmaceutical chemistry continue to influence the industry. Her innovative patents and collaborations highlight her commitment to advancing drug development.